Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2017

Nov 3, 2017

30870_dirs_2017-11-03_3849b535-99db-4cfa-920f-15dd89eed9d8.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2017-11-01

Reporting Person: Blum Robert I (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-11-01 Common Stock S 500 $13.1 Disposed 70180 Direct
2017-11-01 Common Stock S 100 $13.15 Disposed 70080 Direct
2017-11-01 Common Stock S 200 $13.375 Disposed 69880 Direct
2017-11-01 Common Stock S 1100 $13.4 Disposed 68780 Direct
2017-11-01 Common Stock S 100 $13.425 Disposed 68680 Direct
2017-11-01 Common Stock S 200 $13.55 Disposed 68480 Direct
2017-11-01 Common Stock S 100 $13.575 Disposed 68380 Direct
2017-11-01 Common Stock S 1 $13.5804 Disposed 68379 Direct
2017-11-01 Common Stock S 1000 $13.6 Disposed 67379 Direct
2017-11-01 Common Stock S 1000 $13.65 Disposed 66379 Direct
2017-11-01 Common Stock S 100 $13.675 Disposed 66279 Direct
2017-11-01 Common Stock S 347 $13.7 Disposed 65932 Direct
2017-11-01 Common Stock S 252 $13.8 Disposed 65680 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 2083 Indirect
Common Stock 2083 Indirect

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 31, 2017.

F2: Shares held by The Bridget Blum 2003 Irrevocable Trust.

F3: Shares held by The Brittany Blum 2003 Irrevocable Trust.